Abnormal error processing in depressive states: A translational examination in humans and rats

Translational Psychiatry

Volumn 5, Issue 5, 2015, Pages

  Beard, C ^a   Donahue, R J ^a   Dillon, D G ^a   Van't Veer, A ^a   Webber, C ^a   Lee, J ^a   Barrick, E ^a   Hsu, K J ^a   Foti, D ^a   Carroll, F I ^b   Carlezon, W A ^a   Bjorgvinsson T ^a   Pizzagalli, D A ^a  

^a MCLEAN HOSPITAL   (United States)

^b RTI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; KAPPA OPIATE RECEPTOR ANTAGONIST; ANTIDEPRESSANT AGENT; HORMONE;

ABNORMAL BEHAVIOR; ABNORMAL POST ERROR BEHAVIOR; ADULT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ARTICLE; ATTENTION; ATTENTION TEST; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; EXECUTIVE FUNCTION; FEMALE; FIVE CHOICE SERIAL REACTION TIME TASK; HUMAN; MALE; NONHUMAN; PSYCHOPHARMACOTHERAPY; REACTION TIME; RODENT MODEL; RUMINATION; SECONDARY ANALYSIS; TRANQUILIZING ACTIVITY; TRANSLATIONAL RESEARCH; YOUNG ADULT; ADOLESCENT; ANIMAL; CHEMICALLY INDUCED; COGNITIVE THERAPY; DEPRESSIVE DISORDER, MAJOR; DISEASE MODEL; PATHOPHYSIOLOGY; PSYCHOLOGY; PSYCHOMOTOR PERFORMANCE; RAT; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANIMALS; ANTIDEPRESSIVE AGENTS; ATTENTION; COGNITIVE THERAPY; CORTICOTROPIN-RELEASING HORMONE; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; DISEASE MODELS, ANIMAL; FEMALE; HORMONES; HUMANS; MALE; PSYCHOMOTOR PERFORMANCE; RATS; REACTION TIME; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84990932630     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2015.54     Document Type: Article

References (47)

1. Wagner S, Doering B, Helmreich I, Lieb K, Tadic A. A meta-analysis of executive dysfunctions in unipolar major depressive disorder without psychotic symptoms and their changes during antidepressant treatment. Acta Psychiatr Scand 2012; 125: 281-292.
2. Snyder HR. Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: A meta-analysis and review. Psychol Bull 2013; 139: 81-132.
3. Letkiewicz AM, Miller GA, Crocker LD, Warren SL, Infantolino ZP, Mimnaugh KJ, Heller W. Executive function deficits in daily life prospectively predict increases in depressive symptoms. Cognitive Ther Res 2014; 38: 612-620.
4. Ardal G, Hammar A. Is impairment in cognitive inhibition in the acute phase of major depression irreversible? Results from a 10-year follow-up study. Psychol Psychother 2011; 84: 141-150.
5. Trichard C, Martinot JL, Alagille M, Masure MC, Hardy P, Ginestet D et al. Time course of prefrontal lobe dysfunction in severely depressed in-patients: A longitudinal neuropsychological study. Psychol Med 1995; 25: 79-85.
6. Dunkin J, Leuchter AF, Cook IA, Kasl-Godley JE, Abrams M, Rosenberg-Thompson S. Executive dysfunction predicts nonresponse to fluoxetine in major depression. J Affect Disord 2000; 60: 13-23.
7. Eliott R, Sahakian BJ, McKay AP, Herrod JJ, Robbins TW, Paykel ES. Neuropsychological impairments in unipolar depression: The influence of perceived failure on subsequent performance. Psychol Med 1996; 26: 975-989.
8. Beats BC, Sahakian BJ, Levy R. Cognitive performance in tests sensitive to frontal lobe dysfunction in the elderly depressed. Psychol Med 1996; 26: 591-603.
9. Holmes AJ, Pizzagalli DA. Task feedback effects on conflict monitoring and executive control: Relationship to subclinical measures of depression. Emotion 2007; 7: 68-76.
10. Holmes AJ, Pizzagalli DA. Spatiotemporal dynamics of action monitoring dysfunctions in major depressive disorder. Arch Gen Psychiatry 2008; 65: 198-188.
11. Steffens DC, Wagner HR, Levy RM, Horn KA, Krishnan KRR. Performance feedback deficit in geriatric depression. Biol Psychiatry 2001; 50: 358-363.
12. Kessing LV. Cognitive impairment in the euthymic phase of affective disorder. Psychol Med 1998; 28: 1027-1038.
13. Reppermund S, Ising M, Lucae S, Zihl J. Cognitive impairment in unipolar depression is persistent and non-specific: Further evidence for the final common pathway disorder hypothesis. Psychol Med 2009; 39: 603-614.
14. Xu G, Lin K, Rao D, Dang Y, Ouyang H, Guo Y et al. Neuropsychological performance in bipolar I, bipolar II, and unipolar depression patients: A longitudinal, naturalistic study. J Affect Disord 2012; 136: 328-339.
15. Van't Veer A, Yano JM, Ivy Carroll F, Cohen BM, Carlezon WA Jr. Corticotropinreleasing factor (CRF)-induced disruption of attention in rats is blocked by the k-opioid receptor antagonist JDTic. Neuropsychopharmacology 2012; 37: 2809-2816.
16. Robbins T. The 5-choice serial reaction time task: Behavioral pharmacology and functional neurochemistry. Psychopharmacology 2002; 163: 362-380.
17. Paine TA, Tomasiewicz HC, Zhang K, Carlezon WA Jr. Sensitivity of the five-choice serial reaction time task to the effects of various psychotropic drugs in Sprague- Dawley rats. Biol Psychiatry 2007; 62: 687-693.
18. Hauger RL, Risbrough V, Oakley RH, Olivares-Reyes JA, Dautzenberg FM. Role of CRF receptor signaling in stress vulnerability, anxiety, and depression. Ann NY Acad Sci 2009; 1179: 120-143.
19. Binder EB, Nemeroff CB. The CRF system, stress, depression and anxiety - insights from human genetics studies. Mol Psychiatry 2009; 15: 574-588.
20. Nemeroff CB, Widerlöv E, Bissette G, Walléus H, Karlsson I, Eklund K et al. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 1984; 226: 1342-1344.
21. Banki CM, Bissette G, Arato M, O'Connor L, Nemeroff CB. CSF corticotropinreleasing factor-like immunoreactivity in depression and schizophrenia. Am J Psychiatry 1987; 144: 873-877.
22. Dunn AJ, Berridge CW. Corticotropin-releasing factor administration elicits a stress-like activation of cerebral catecholaminergic systems. Pharmacol Biochem Behav 1987; 27: 685-691.
23. Macey DJ, Koob GF, Markou A. CRF and urocortin decreased brain stimulation reward in the rat: Reversal by a CRF receptor antagonist. Brain Res 2000; 866: 82-91.
24. Carroll FI, Carlezon WA Jr. Development of kappa-opioid receptor antagonists. J Med Chem 2013; 56: 2178-2195.
25. Beard C, Björgvinsson T. Commentary on psychological vulnerability: An integrative approach. J Integr Psychother 2013; 23: 281-283.
26. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez J, Conde D. Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42: 377-381.
27. Andresen EM, Malmgren JA, Carter WB, Patrick DL. Screening for depression in well older adults: Evaluation of a short form of the CES-D (center for epidemiologic studies depression scale). Am J Prev Med 1994; 10: 77-84.
28. Eisen SV, Normand SL, Belanger AJ, Spiro A, Esch D. The revised behavior and symptom identification scale (BASIS-R): Reliability and validity. Med Care 2004; 42: 1230-1241.
29. Jacob KL, Christopher MS, Neuhaus EC. Development and validation of the cognitive-behavioral therapy skills questionnaire. Behav Modif 2011; 35: 595-618.
30. Treynor W, Gonzalez R, Nolen-Hoeksema S. Rumination reconsidered: A psychometric analysis. Cognitive Ther Res 2003; 27: 247-259.
31. Derryberry D, Reed MA. Anxiety-related attentional biases and their regulation by attentional control. J Abnorm Psychol 2002; 111: 225-236.
32. Armstrong T, Zald DH, Olatunji BO. Attentional control in OCD and GAD: Specificity and associations with core cognitive symptoms. Behav Res Ther 2011; 49: 756-762.
33. Ólafsson RP, Smárib J, Gumundsdóttirb F, Ólafsdóttirb G, Harardóttirb HL, Einarssonb SM. Self reported attentional control with the Attentional Control Scale: Factor structure and relationship with symptoms of anxiety and depression. J Anxiety Disord 2011; 25: 777-782.
34. Judah MR, Grant DM, Mills AC, Lechner WV. Factor structure and validation of the attentional control scale. Cogn Emot 2014; 28: 433-451.
35. Reinholdt-Dunne ML, Mogg K, Bradley BP. Attentional control: Relationships between self-report and behavioral measures, and symptoms of anxiety and depression. Cogn Emot 2013; 27: 430-440.
36. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59: 22-33.
37. Beard C, Björgvinsson T. Beyond generalized anxiety disorder: Psychometric properties of the GAD-7 in a heterogeneous psychiatric sample. J Anxiety Disord 2014; 28: 547-552.
38. Eriksen BA, Eriksen CW. Effects of noise letters upon the identification of a target letter in a nonsearch task. Percept Psychophys 1974; 16: 143-149.
39. Holmes AJ, Bogdan R, Pizzagalli DA. Serotonin transporter genotype and action monitoring dysfunction: A possible substrate underlying increased vulnerability to depression. Neuropsychopharmacology 2010; 35: 1186-1197.
40. Laming D. Autocorrelation of choice-reaction times. Acta Psychol 1979; 43: 381-412.
41. Rabbitt PM. Errors and error correction in choice-response tasks. J Exp Psychol 1966; 71: 264-272.
42. Pizzagalli DA, Peccoralo LA, Davidson RJ, Cohen JD. Resting anterior cingulate activity and abnormal responses to errors in subjects with elevated depressive symptoms: A 128-channel EEG study. Hum Brain Mapp 2006; 27: 185-201.
43. Van't Veer A, Carlezon WA Jr. Role of kappa-opioid receptors in stress and anxiety. Psychopharmacology 2013; 229: 435-452.
44. Weinberg A, Kotov R, Proudfit GH. Neural indicators of error processing in generalized anxiety disorder, obsessive-compulsive disorder, and major depressive disorder. J Psychol 2015; 124: 172-185.
45. Elgamal S, McKinnon MC, Ramakrishnan K, Joffe RT, MacQueen G. Successful computer-assisted cognitive remediation therapy in patients with unipolar depression: A proof of principle study. Psychol Med 2007; 37: 1229-1238.
46. Owens M, Koster EH, Derakshan N. Improving attention control in dysphoria through cognitive training: Transfer effects on working memory capacity and filtering efficiency. Psychophysiology 2010; 50: 297-307.
47. Hyman S. Depression needs large human-genetics studies. Nature 2014; 515: 189-191.